Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells

Cancer Gene Therapy

Volumn 19, Issue 5, 2012, Pages 358-366

  Arima, H ^a   Arizono, M ^a   Higashi, T ^a   Yoshimatsu, A ^a   Ikeda, H ^a   Motoyama, K ^a   Hattori, K ^b   Takeuchi, T ^b   Hirayama, F ^c   Uekama, K ^c  

^a KUMAMOTO UNIVERSITY   (Japan)

^b TOKYO POLYTECHNIC UNIVERSITY   (Japan)

^c SOJO UNIVERSITY   (Japan)

Author keywords

cyclodextrin; folate; gene transfer; PAMAM dendrimer

Indexed keywords

ALPHA CYCLODEXTRIN; DENDRIMER; DNA; FOLATE RECEPTOR; FOLIC ACID; MACROGOL; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL SPECIFICITY; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; ZETA POTENTIAL;

ALPHA-CYCLODEXTRINS; ANIMALS; DENDRIMERS; DNA; FOLIC ACID; GENE TRANSFER TECHNIQUES; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; POLYAMINES; TRANSFECTION;

MUS;

EID: 84859925443     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2012.9     Document Type: Article

References (47)

1. Tomalia D, Baker H, Dewald J, Hall M, Kallos G, Martin S et al. A new class of polymers: starburt-dendritic macromolecules. Polymer J 1985; 17: 117-132.
2. Esfand R, Tomalia DA. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov Today 2001; 6: 427-436. (Pubitemid 32328297)
3. Braun CS, Vetro JA, Tomalia DA, Koe GS, Koe JG, Middaugh CR. Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J Pharm Sci 2005; 94: 423-436. (Pubitemid 40293337)
4. Fant K, Esbjorner EK, Lincoln P, Norden B. DNA condensation by PAMAM dendrimers: self-assembly characteristics and effect on transcription. Biochemistry 2008; 47: 1732-1740. (Pubitemid 351231222)
5. Dutta T, Jain NK, McMillan NA, Parekh HS. Dendrimer nanocarriers as versatile vectors in gene delivery. Nanomedicine 2010; 6: 25-34.
6. Hui Z, He ZG, Zheng L, Li GY, Shen SR, Li XL. Studies on polyamidoamine dendrimers as efficient gene delivery vector. J Biomater Appl 2008; 22: 527-544.
7. Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov 2004; 3: 1023-1035. (Pubitemid 39642365)
8. Uekama K, Hirayama F, Irie T. Cyclodextrin drug carrier systems. Chem Rev 1998; 98: 2045-2076. (Pubitemid 128633447)
9. Stella VJ, Rajewski RA. Cyclodextrins: their future in drug formulation and delivery. Pharm Res 1997; 14: 556-567. (Pubitemid 27220271)
10. Ortiz Mellet C, Garcia Fernandez JM, Benito JM. Cyclodextrin-based gene delivery systems. Chem Soc Rev 2011; 40: 1586-1608.
11. Roessler BJ, Bielinska AU, Janczak K, Lee I, Baker Jr JR. Substituted betacyclodextrins interact with PAMAM dendrimer-DNA complexes and modify transfection efficiency. Biochem Biophys Res Commun 2001; 283: 124-129. (Pubitemid 32912547)
12. Croyle MA, Roessler BJ, Hsu CP, Sun R, Amidon GL. Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine. Pharm Res 1998; 15: 1348-1355. (Pubitemid 28427920)
13. Abdou S, Collomb J, Sallas F, Marsura A, Finance C. Beta-cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence. Arch Virol 1997; 142: 1585-1602. (Pubitemid 27347738)
14. Arima H, Kihara F, Hirayama F, Uekama K. Enhancement of gene expression by polyamidoamine dendrimer conjugates with a-, b-, and c-cyclodextrins. Bioconjug Chem 2001; 12: 476-484. (Pubitemid 32696220)
15. Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K. Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with a-cyclodextrin. Bioconjug Chem 2002; 13: 1211-1219. (Pubitemid 35420012)
16. Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K. In vitro and in vivo gene transfer by an optimized a-cyclodextrin conjugate with polyamidoamine dendrimer. Bioconjug Chem 2003; 14: 342-350. (Pubitemid 36348657)
17. Wada K, Arima H, Tsutsumi T, Chihara Y, Hattori K, Hirayama F et al. Improvement of gene delivery mediated by mannosylated dendrimer/a-cyclodextrin conjugates. J Control Release 2005; 104: 397-413. (Pubitemid 40724937)
18. Wada K, Arima H, Tsutsumi T, Hirayama F, Uekama K. Enhancing effects of galactosylated dendrimer/a-cyclodextrin conjugates on gene transfer efficiency. Biol Pharm Bull 2005; 28: 500-505. (Pubitemid 40879976)
19. Arima H, Chihara Y, Arizono M, Yamashita S, Wada K, Hirayama F et al. Enhancement of gene transfer activity mediated by mannosylated dendrimer/a-cyclodextrin conjugate (generation 3, G3). J Control Release 2006; 116:64-74. (Pubitemid 44792299)
20. Arima H, Yamashita S, Mori Y, Hayashi Y, Motoyama K, Hattori K et al. In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/a- cyclodextrin conjugates (G2) into hepatocytes. J Control Release 2010; 146: 106-117.
21. Sahoo SK, Parveen S, Panda JJ. The present and future of nanotechnology in human health care. Nanomedicine 2007; 3: 20-31. (Pubitemid 46428187)
22. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev 2009; 109:259-302.
23. Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000; 41: 147-162. (Pubitemid 30122955)
24. Ward CM. Folate-targeted non-viral DNA vectors for cancer gene therapy. Curr Opin Mol Ther 2000; 2: 182-187. (Pubitemid 30212268)
25. Zhao Y, Liu S, Li Y, Jiang W, Chang Y, Pan S et al. Synthesis and grafting of folate-PEG-PAMAM conjugates onto quantum dots for selective targeting of folatereceptor-positive tumor cells. J Colloid Interface Sci 2010; 350: 44-50.
26. Konda SD, Aref M, Wang S, Brechbiel M, Wiener EC. Specific targeting of folatedendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Magma 2001; 12: 104-113. (Pubitemid 32510128)
27. Shukla R, Thomas TP, Desai AM, Kotlyar A, Park SJ, Baker JR. HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2mAb. Nanotechnology 2008; 19: 295102.
28. Singh I, Rehni AK, Kalra R, Joshi G, Kumar M. Dendrimers and their pharmaceutical applications-a review. Pharmazie 2008; 63: 491-496.
29. Majoros IJ, Williams CR, Baker Jr JR. Current dendrimer applications in cancer diagnosis and therapy. Curr Top Med Chem 2008; 8: 1165-1179.
30. Oh IK, Mok H, Park TG. Folate immobilized and PEGylated adenovirus for retargeting to tumor cells. Bioconjug Chem 2006; 17: 721-727. (Pubitemid 43794382)
31. Antony AC, Kane MA, Portillo RM, Elwood PC, Kolhouse JF. Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells. J Biol Chem 1985; 260: 14911-14917. (Pubitemid 16188350)
32. Stephenson SM, Low PS, Lee RJ. Folate receptor-mediated targeting of liposomal drugs to cancer cells. Methods Enzymol 2004; 387: 33-50.
33. Leamon CP, Weigl D, Hendren RW. Folate copolymer-mediated transfection of cultured cells. Bioconjug Chem 1999; 10: 947-957.
34. Gebhart CL, Kabanov AV. Evaluation of polyplexes as gene transfer agents. J Control Release 2001; 73: 401-416. (Pubitemid 32539266)
35. Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat Rev Drug Discov 2005; 4: 581-593. (Pubitemid 40975711)
36. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem 2009; 78: 857-902.
37. Arima H, Motoyama K. Recent findings concerning PAMAM dendrimer conjugates with cyclodextrins as carriers of DNA and RNA. Sensors 2009; 9: 6346-6361.
38. Albertazzi L, Serresi M, Albanese A, Beltram F. Dendrimer internalization and intracellular trafficking in living cells. Mol Pharm 2010; 7: 680-688.
39. Reddy JA, Dean D, Kennedy MD, Low PS. Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J Pharm Sci 1999; 88: 1112-1118. (Pubitemid 29526294)
40. Reddy JA, Low PS. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit Rev Ther Drug Carrier Syst 1998; 15: 587-627. (Pubitemid 29006581)
41. Letrou-Bonneval E, Chevre R, Lambert O, Costet P, Andre C, Tellier C et al. Galactosylated multimodular lipoplexes for specific gene transfer into primary hepatocytes. J Gene Med 2008; 10: 1198-1209.
42. Thomas M, Klibanov AM. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci USA 2002; 99: 14640-14645. (Pubitemid 35334537)
43. Godbey WT, Wu KK, Hirasaki GJ, Mikos AG. Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency. Gene Ther 1999; 6:1380-1388. (Pubitemid 29396726)
44. Gabrielson NP, Pack DW. Acetylation of polyethylenimine enhances gene delivery via weakened polymer/DNA interactions. Biomacromolecules 2006; 7:2427-2435. (Pubitemid 44336356)
45. Navarro G, Maiwald G, Haase R, Rogach AL, Wagner E, de Ilarduya CT et al. Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery. J Control Release 2010; 146: 99-105.
46. Navarro G, Tros de Ilarduya C. Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo. Nanomedicine 2009; 5: 287-297.
47. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46: 6387-6392. (Pubitemid 17221789)